Figure 1.
(A) S1P inhibits acute Lp response to PAF. Representative data from one experiment show that treatment with S1P (1 µM) inhibits the first test with PAF (10 nM), whereas a second test in the absence of S1P after recovery to baseline shows a typical PAF response. (B) Dose–response relation for inhibition of PAF by S1P. The ratio of the peak Lp response to PAF (10 nM) in the presence of S1P to the peak value in the absence of S1P is shown. Both 1 and 5 µM S1P inhibit about 65% of the acute Lp peak response. Control value shows that repeated treatment with PAF yields comparable peaks (*different from control, P < 0.05, Wilcoxon's signed-rank test, n for each group shown in parentheses).
